Article

CWRU receives $1 million grant for eye disease research

Four researchers from Case Western Reserve University Medical School, Cleveland, OH, received a $1.04 million grant to continue their research into diseases including age-related macular degeneration.

Cleveland, OH-Four researchers from Case Western Reserve University (CWRU) Medical School, Cleveland, OH, received a $1.04 million grant to continue their research into diseases including age-related macular degeneration (AMD).

The funds will come from the Research to Prevent Blindness Foundation, which donated more than $10 million in research grants in 2008 and supports vision research throughout the United States. The organization has given more than 2.7 million to CWRU since 1997.

Irina A. Pikuleva, PhD, an ophthalmology and pharmacology professor, studies cytochromes P450, a critical enzyme that helps eliminate cholesterol, received the majority of the latest funding. Dr. Pikuleva will use $650,000 from the foundation plus additional funding to determine whether there are mechanisms similar to cytochromes P450 involved in atherosclerosis, Alzheimer’s disease, and AMD.

Paul Shin-Hyun Park, PhD, an assistant professor in ophthalmology and visual sciences, will use a 4-year, $200,000 grant to help study retina pigments that could have an impact on diseases including AMD.

Ram Nagaraj, PhD, will use a $75,000 grant to continue work researching cataracts and diabetic retinopathy.

A $115,000 unrestricted grant also has been renewed by the foundation for Jonathan Lass, MD, chairman of the Ophthalmology and Visual Sciences Department and director of the University Hospitals Case Medical Center Eye Institute. Dr. Lass will use the money to invest in new research programs and advance the research mission of the department.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.